<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">APM</journal-id><journal-title-group><journal-title>Advances in Precision Medicine</journal-title></journal-title-group><issn>2424-8592</issn><eissn>2424-9106</eissn><publisher><publisher-name>WHIOCE PUBLISHING PTE. LTD.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18063/APM.v11i5.2040</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Network Pharmacology-Based Investigation of the Mechanism by Which Sijunzi Decoction Modulates Microglial Activation and Improves Diabetic Cognitive Impairment</title><url>https://artdesignp.com/journal/APM/11/5/10.18063/APM.v11i5.2040</url><author>RuanTian</author><pub-date pub-type="publication-year"><year>2026</year></pub-date><volume>11</volume><issue>5</issue><history><date date-type="pub"><published-time>2026-05-26</published-time></date></history><abstract>Diabetic cognitive impairment (DCI) is a chronic complication of type 2 diabetes mellitus (T2DM) in which persistent neuroinflammation driven by microglial activation plays a central pathogenic role. Sijunzi decoction (SJZD), a classical formula composed of Ginseng Radix et Rhizoma&amp;nbsp;(Renshen), Atractylodis&amp;nbsp;Macrocephalae Rhizoma&amp;nbsp;(Baizhu), Poria (Fuling) and Glycyrrhizae Radix et Rhizoma Praeparata cum Melle&amp;nbsp;(Gancao), has demonstrated cognition-improving activity in diabetic models, yet its molecular mechanism remains unclear. Using a fully reproducible network-pharmacology pipeline, we retrieved 136 active compounds of the four component herbs from TCMSP (oral bioavailability &amp;ge; 30%, drug-likeness &amp;ge; 0.18) and mapped them to 413 human protein targets via UniProt. Disease targets were obtained from the Open Targets platform: 2184 targets for cognitive impairment / Alzheimer disease and 1500 for T2DM. The intersection of SJZD targets with the cognitive-impairment gene set yielded 71 putative DCI targets. A STRING protein&amp;ndash;protein interaction network (confidence &amp;ge; 0.40) of these targets contained 71 nodes and 280 edges (density 0.113, 5 connected components); topology analysis identified GSK3B, CTNNB1, HIF1A, CREB1, CAV1, SLC2A4, BACE1, NOS3 and JAK2 as core hub genes. Enrichr-based Gene Ontology and KEGG analysis showed that these targets were significantly enriched in adenylate-cyclase-activating adrenergic receptor signaling, G-protein-coupled receptor signaling, the insulin resistance pathway (hsa04931), neuroactive ligand&amp;ndash;receptor interaction (hsa04080), calcium signaling (hsa04020), the cholinergic synapse and the &amp;ldquo;neuroinflammation and glutamatergic signaling&amp;rdquo; WikiPathway. These results indicate that SJZD ameliorates DCI by simultaneously regulating insulin resistance, neurotransmission and neuroinflammation, processes intimately linked to microglial activation, thereby providing a mechanistic rationale and candidate targets for subsequent experimental validation.</abstract><keywords>Sijunzi decoction,Diabetic cognitive impairment,Network pharmacology,Microglia; Insulin resistance,Neuroinflammation</keywords></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>[1] Tumminia A, Vinciguerra F, Parisi M, et al., 2018, Type 2 Diabetes Mellitus and Alzheimer&amp;rsquo;s Disease: Role of Insulin Signalling and Therapeutic Implications. International Journal of Molecular Sciences, 19(11): 3306.
[2] Hopkins A, 2008, Network Pharmacology: The Next Paradigm in Drug Discovery. Nature Chemical Biology, 4(11): 682&amp;ndash;690.
[3] Che Y, He J, Li X, et al., 2022, Overexpression of microRNA-381-3p Ameliorates Hypoxia/Ischemia-Induced Neuronal Damage and Microglial Inflammation via Regulating the CCR2/NF-&amp;kappa;B Axis. Bioengineered, 13(5): 6839&amp;ndash;6855.
[4] Yang L, Meng L, Zhou Q, 2024, Sijunzi Decoction Improves Cognition and Reduces Hippocampal A&amp;beta;/Tau and Inflammatory Cytokines in T2DM Mice, thesis, Yunnan Medical &amp;amp; Health College.
[5] Liu P, Sun R, Zhang L, et al., 2020, Network Pharmacology Study of the Mechanism of Sijunzi Decoction in Type 2 Diabetes. Zhong Cao Yao, 51(6): 1548&amp;ndash;1558.
[6] Ru J, Li P, Wang J, et al., 2014, TCMSP: A Database of Systems Pharmacology for Drug Discovery from Herbal Medicines. Journal of Cheminformatics, 6: 13.
[7] The UniProt Consortium, 2018, UniProt: The Universal Protein Knowledgebase. Nucleic Acids Research, 46(5): 2699.
[8] Oportunidades/Open Targets Platform, 2023, Open Targets Genetics: Systematic Identification of Trait-Associated Genes. Nucleic Acids Research, 51(D1): D1335&amp;ndash;D1342.
[9] Szklarczyk D, Kirsch R, Koutrouli M, et al., 2023, The STRING Database in 2023: Protein&amp;ndash;Protein Association Networks and Functional Enrichment Analyses for Any Sequenced Genome of Interest. Nucleic Acids Research, 51(D1): D638&amp;ndash;D646.
[10] Kuleshov M, Jones M, Rouillard A, et al., 2016, Enrichr: A Comprehensive Gene Set Enrichment Analysis Web Server 2016 Update. Nucleic Acids Research, 44(W1): W90&amp;ndash;W97.
[11] Hanger D, Noble W, 2009, The Tau Kinase GSK3B Is Associated with Dementia. Nature Clinical Practice Neurology, 5(2): 65&amp;ndash;66.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
